BAC
Bank of America Corporation
BAC has the edge over GNW overall, supported by stronger modeled upside and lower modeled downside.
GNW
Genworth Financial, Inc.
GNW trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
GNW Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
GNW's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like GNW.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over GNW in the historical PE scenario, which offers more potential upside but is not a forecast.
GNW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.5x | $0.35 | -96% |
| Fair | 9.5x | $1.33 | -84% |
| Expensive | 32x | $4.44 | -47% |
| Current | 60x | $8.41 | — |
Historical ranges are pointers, not guarantees.
GNW's PE is in its expensive range at 60x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
GNW Forward outlook
There aren't enough analyst estimates for GNW to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over GNW on earnings, with more consistent year-over-year improvement.
GNW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.14 | -74% |
| Q2 2026 | $0.53 | +18% |
| Q1 2026 | $0.53 | +6% |
| Q4 2025 | $0.54 | -21% |
| Q3 2025 | $0.54 | +170% |
| Q2 2025 | $0.45 | +543% |
| Q1 2025 | $0.50 | +163% |
| Q4 2024 | $0.68 | +$0.68 |
GNW's earnings per share have fallen from their peak: $0.14 over the past year, against $2.18 in mid-2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over GNW on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over GNW on profitability, with a higher operating margin.
GNW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.8B | -7.3% |
| Q2 2026 | $1.9B | +5.8% |
| Q1 2026 | $1.8B | -0.5% |
| Q4 2025 | $1.8B | +0.1% |
| Q3 2025 | $1.9B | +2.9% |
| Q2 2025 | $1.8B | +1.5% |
| Q1 2025 | $1.8B | -4.2% |
| Q4 2024 | $1.8B | -6.8% |
GNW's revenue fell from its 2020 peak and has held roughly level since: $1.8B last quarter, down 7.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.1% | -8.5 points |
| Q2 2026 | 5.7% | +1.9 points |
| Q1 2026 | 6.3% | +3.4 points |
| Q4 2025 | 1% | -2.1 points |
| Q3 2025 | 8.5% | +5.9 points |
| Q2 2025 | 3.8% | -3.3 points |
| Q1 2025 | 2.9% | -1.7 points |
| Q4 2024 | 3.1% | +15 points |
GNW's operating margin was −0.1% last quarter, down 8.5 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
GNW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $100M | +15% |
| Q2 2026 | $52M | +767% |
| Q1 2026 | $91M | +168% |
| Q4 2025 | $200M | +641% |
| Q3 2025 | $87M | -46% |
| Q2 2025 | $6M | -14% |
| Q1 2025 | $34M | +$141M |
| Q4 2024 | $27M | -82% |
GNW has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
GNW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.6x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
GNW has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
GNW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.9 | Neutral |
| Stochastic | 3.3 | Oversold |
GNW's weekly RSI is 37 (neutral) and its Stochastic is 3 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over GNW on valuation relative to its sector.
GNW PE vs Financial Services Sector
| Metric | GNW | Sector median | Relative |
|---|---|---|---|
| PE | 60x | 13x | 361% above |
| PE % | 91 | 63 | 28 pts above |
GNW is trading at 60x earnings, a 361% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
GNW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.03 | 6.9% below |
| 20 week MA | $9.57 | 12% below |
| 50 week MA | $9.06 | 7.2% below |
| 100 week MA | $8.34 | 0.8% above |
| 200 week MA | $7.24 | 16% above |
GNW has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
GNW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.36 | $4.36 | 0% |
| 2021 | $4.36 | $4.09 | -6.2% |
| 2022 | $4.09 | $5.27 | +29% |
| 2023 | $5.27 | $6.68 | +27% |
| 2024 | $6.68 | $6.97 | +4.3% |
| 2025 | $6.97 | $9.14 | +31% |
| 2026 YTD | $9.14 | $8.41 | -8% |
GNW has the edge over BAC on returns for 2026, with the stronger performance.